drugset / Trial / NCT06066606
U-LABA/ICS Effects on Exercise Performance, Vilanterol
RandomizedCrossoverQuadruple-blindBasic science
Summary
The purpose of the project is to investigate exercise performance in humans following bronchodilation induced by acute inhalation of beta2-agonist vilanterol + fluticasone furoate
Timeline
- Start
- 2023-10-03
- Primary completion
- 2026-07-15
- Completion
- 2026-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone Furoate | Other / unclassified | — | Inhaled |
| Subject | Vilanterol | Other / unclassified | 25 ug | Inhaled |
| Subject | Vilanterol | Other / unclassified | 100 ug | Inhaled |
Indications
No indication recorded.